MASOUD KHAYYAMI, CHAIRMAN
Born 1963. Doctor of Biochemistry at Lund University. 

Extensive experience from research in medicine, medtech and biotechnology. Extensive entrepreneurial experience from, among others, Prolight Diagnostics AB (public limited company), SpectraCure AB (publ), GASPOROX AB (publ) and expert knowledge in applied medicine, microbiology and biotechnology, especially in the development of different types of biomolecules for commercial use and biological applications. 

Board member and CEO of Spectracure AB (publ), Prolight Diagnostics AB (publ). 

Number of private, associates and companies shares: 6,547,990 

Number of warrants: 126,000 

Dependent on the Company’s major shareholders, but independent in relation to the Company and corporate management.